Published in PLoS Negl Trop Dis on January 26, 2010
Snakebite profile from a medical college in rural setting in the hills of Himachal Pradesh, India. Indian J Crit Care Med (2014) 1.28
Incidence of snake bites in kashan, iran during an eight year period (2004-2011). Arch Trauma Res (2012) 1.04
Clinical profile, species-specific severity grading, and outcome determinants of snake envenomation: An Indian tertiary care hospital-based prospective study. Indian J Crit Care Med (2012) 1.01
Neurotoxin envenomation mimicking brain death in a child: A case report and review of literature. Indian J Anaesth (2014) 0.95
Effectiveness of rapid transport of victims and community health education on snake bite fatalities in rural Nepal. Am J Trop Med Hyg (2013) 0.95
Neurotoxicity in snakebite--the limits of our knowledge. PLoS Negl Trop Dis (2013) 0.95
Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain. Proc Natl Acad Sci U S A (2010) 0.92
Snakebites are associated with poverty, weather fluctuations, and El Niño. Sci Adv (2015) 0.90
Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India. PLoS One (2013) 0.88
Severe Neurotoxic Envenoming and Cardiac Complications after the Bite of a 'Sind Krait' (Bungarus cf. sindanus) in Maharashtra, India. Trop Med Health (2012) 0.88
Detection of venom after antivenom is not associated with persistent coagulopathy in a prospective cohort of Russell's viper (Daboia russelii) envenomings. PLoS Negl Trop Dis (2014) 0.88
Neuromuscular Effects of Common Krait (Bungarus caeruleus) Envenoming in Sri Lanka. PLoS Negl Trop Dis (2016) 0.87
The effectiveness of a 'train the trainer' model of resuscitation education for rural peripheral hospital doctors in Sri Lanka. PLoS One (2013) 0.86
Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry. Toxins (Basel) (2013) 0.85
Venom and Purified Toxins of the Spectacled Cobra (Naja naja) from Pakistan: Insights into Toxicity and Antivenom Neutralization. Am J Trop Med Hyg (2016) 0.84
Do herbal medicines have potential for managing snake bite envenomation? Toxicol Int (2012) 0.84
Dangerous snakes, deadly snakes and medically important snakes. J Venom Anim Toxins Incl Trop Dis (2013) 0.83
Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation. PLoS Negl Trop Dis (2013) 0.83
The use of ecological niche modeling to infer potential risk areas of snakebite in the Mexican state of Veracruz. PLoS One (2014) 0.81
Clinico-epidemiological Profile of Snake Bites over 6-year Period from a Rural Secondary Care Centre of Northern India: A Descriptive Study. Toxicol Int (2016) 0.80
Snakebites in Two Rural Districts in Lao PDR: Community-Based Surveys Disclose High Incidence of an Invisible Public Health Problem. PLoS Negl Trop Dis (2015) 0.79
'A life threatening scratch on little toe' - at most clinical suspicion the essential key in management of snake bite. Asian Pac J Trop Biomed (2012) 0.79
A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation. J Biol Chem (2012) 0.79
Snakebite in bedroom kills a physician in Cameroon: a case report. Pan Afr Med J (2016) 0.78
Ethnobotanical survey of folklore plants used in treatment of snakebite in Paschim Medinipur district, West Bengal. Asian Pac J Trop Biomed (2014) 0.78
Viper and cobra venom neutralization by alginate coated multicomponent polyvalent antivenom administered by the oral route. PLoS Negl Trop Dis (2014) 0.78
Soluble P-selectin rescues viper venom-induced mortality through anti-inflammatory properties and PSGL-1 pathway-mediated correction of hemostasis. Sci Rep (2016) 0.76
Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation. Clin Case Rep (2013) 0.76
Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy. PLoS Negl Trop Dis (2015) 0.75
Snakebite Envenoming - A Combined Density Equalizing Mapping and Scientometric Analysis of the Publication History. PLoS Negl Trop Dis (2016) 0.75
Awareness and perceptions on prevention, first aid and treatment of snakebites among Sri Lankan farmers: a knowledge practice mismatch? J Occup Med Toxicol (2014) 0.75
The Protocol of Choice for Treatment of Snake Bite. Adv Med (2016) 0.75
Predictors of the development of post-snakebite compartment syndrome. Scand J Trauma Resusc Emerg Med (2015) 0.75
Snakebite in Korea: A Guideline to Primary Surgical Management. Yonsei Med J (2015) 0.75
A Survey of Snakebite Knowledge among Field Forces in China. Int J Environ Res Public Health (2016) 0.75
Taxonomical outlines of bio-diversity of Karnataka in a 14th century Kannada toxicology text Khagendra Mani Darpana. Asian Pac J Trop Biomed (2013) 0.75
Fatal neurotoxic envenomation following the bite of a greater black krait (Bungarus niger) in Nepal: a case report. J Venom Anim Toxins Incl Trop Dis (2016) 0.75
Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming. PLoS Negl Trop Dis (2016) 0.75
Shewanella infection of snake bites: a twelve-year retrospective study. Clinics (Sao Paulo) (2012) 0.75
Epidemiological study of snakebites in Ardabil Province (Iran). Electron Physician (2017) 0.75
Snake bite induced cellulitis leading to infected open dislocation of the first metacarpophalangeal joint - A rare complication. J Clin Orthop Trauma (2015) 0.75
+Ophitoxaemia and myocardial infarction--the issues during primary angioplasty: a review. BMJ Case Rep (2014) 0.75
A study of snake bite among children presenting to a paediatric ward in the main Teaching Hospital of North Central province of Sri Lanka. BMC Res Notes (2014) 0.75
Multisystem failure and death due to extensive hemorrhaging and brain herniation subsequent to a bite by an unidentified snake. Trop Med Health (2016) 0.75
Partnerships in global health and collaborative governance: lessons learnt from the Division of Tropical and Humanitarian Medicine at the Geneva University Hospitals. Global Health (2016) 0.75
Ethnopharmacological survey of medicinal plants used by traditional healers and indigenous people in chittagong hill tracts, bangladesh, for the treatment of snakebite. Evid Based Complement Alternat Med (2015) 0.75
Clinicopathological spectrum of snake bite-induced acute kidney injury from India. World J Nephrol (2017) 0.75
Paroxysmal Atrial Fibrillation due to Venomous Snake Bite. J Clin Diagn Res (2017) 0.75
Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise. Br J Haematol (2017) 0.75
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med (2008) 6.41
Snake-bites: appraisal of the global situation. Bull World Health Organ (1998) 4.03
Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med (2006) 2.87
Crisis in snake antivenom supply for Africa. Lancet (2000) 2.66
High-dose anti-snake venom versus low-dose anti-snake venom in the treatment of poisonous snake bites--a critical study. J Assoc Physicians India (2004) 2.54
Randomized controlled trial on the effective dose of anti-snake venom in cases of snake bite with systemic envenomation. J Assoc Physicians India (1999) 2.50
Parallel infusion of hydrocortisone +/- chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust (2004) 2.43
Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg (2004) 2.42
Tourniquet ineffectiveness to reduce the severity of envenoming after Crotalus durissus snake bite in Belo Horizonte, Minas Gerais, Brazil. Toxicon (1998) 2.07
Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes. Emerg Med J (2008) 2.02
Epidemiology of snake bite in the district of Burdwan, West Bengal. J Indian Med Assoc (1992) 1.91
Rationalisation of first-aid measures for elapid snakebite. Lancet (1979) 1.90
Snake envenomation in a north Indian hospital. Emerg Med J (2005) 1.84
Common krait (Bungarus caeruleus) bite in Anuradhapura, Sri Lanka: a prospective clinical study, 1996-98. Postgrad Med J (2002) 1.83
Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming. Emerg Med J (2005) 1.82
Management of snake-bite in rural Maharashtra: a 10-year experience. Natl Med J India (2005) 1.80
Snakes of medical importance in India: is the concept of the "Big 4" still relevant and useful? Wilderness Environ Med (2007) 1.66
Epidemiological profile of snake-bite cases from Andhra Pradesh using immunoanalytical approach. Indian J Med Res (2007) 1.51
Distinctive epidemiologic and clinical features of common krait (Bungarus caeruleus) bites in Sri Lanka. Am J Trop Med Hyg (2008) 1.51
Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans R Soc Trop Med Hyg (1990) 1.49
A clinico-epidemiological study of snake bite in Nepal. Trop Doct (1998) 1.47
Snake venoms in science and clinical medicine. 1. Russell's viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg (1990) 1.46
Pressure immobilisation for snakebite in southern Africa remains speculative. S Afr Med J (1994) 1.44
Profile of snakebite envenoming in western Maharashtra, India. Trans R Soc Trop Med Hyg (2002) 1.41
Epidemiology and clinical picture of the Russell's viper (Daboia russelii russelii) bite in Anuradhapura, Sri Lanka: a prospective study of 336 patients. Southeast Asian J Trop Med Public Health (2003) 1.37
Epidemiologic trend changes in acute renal failure--a tertiary center experience from South India. Ren Fail (2006) 1.33
Snake venom poisoning: experience with 633 cases. Indian Pediatr (1994) 1.32
Underestimation of snakebite mortality by hospital statistics in the Monaragala District of Sri Lanka. Trans R Soc Trop Med Hyg (2005) 1.31
Envenoming by the common krait (Bungarus caeruleus) and Asian cobra (Naja naja): clinical manifestations and their management in a rural setting. Wilderness Environ Med (2004) 1.31
COBRA-BITES. Br Med J (1964) 1.30
An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg (2001) 1.29
Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med (1988) 1.29
Profile of snakebite envenoming in rural Maharashtra, India. J Assoc Physicians India (2008) 1.28
Frequent and potentially fatal envenoming by hump-nosed pit vipers (Hypnale hypnale and H. nepa) in Sri Lanka: lack of effective antivenom. Trans R Soc Trop Med Hyg (2008) 1.24
Snake bite in India. Indian J Med Res (1954) 1.23
Protection against snake bites by sleeping under a bed net in southeastern Nepal. Am J Trop Med Hyg (2007) 1.17
Micro-ELISA for detecting and assaying snake venom and venom-antibody. Lancet (1977) 1.15
Management of respiratory failure in severe neuroparalytic snake envenomation. Neurol India (2001) 1.12
Excessive fibrinolysis: the coagulopathy following Merrem's hump-nosed viper (Hypnale hypnale) bites. Am J Trop Med Hyg (1998) 1.11
Clinical predictors of in-hospital mortality in patients with snake bite: a retrospective study from a rural hospital in central India. Trop Med Int Health (2006) 1.07
Snakebite-reappraisal of the situation in Eastern Nepal. Toxicon (2003) 1.05
A phylogeny of four mitochondrial gene regions suggests a revised taxonomy for Asian pitvipers (Trimeresurus and Ovophis). Mol Phylogenet Evol (2004) 1.05
First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg (2006) 1.02
Epidemiology, clinical profile and management issues of cobra (Naja naja) bites in Sri Lanka: first authenticated case series. Trans R Soc Trop Med Hyg (2009) 1.01
Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr Pharm Des (2007) 0.98
Use of antivenom serum in snake bite: a prospective study of hospital practice in the Gampaha district. Ceylon Med J (2000) 0.97
Correlation between timing of ASV administration and complications in snake bites. J Assoc Physicians India (2006) 0.97
Rediscovery of severe saw-scaled viper (Echis sochureki) envenoming in the Thar desert region of Rajasthan, India. Wilderness Environ Med (2007) 0.97
A new monospecific ovine Fab fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper (Daboia Russelii Russelii): a preliminary dose-finding and pharmacokinetic study. Am J Trop Med Hyg (1999) 0.97
Region-specific neutralization of Indian cobra (Naja naja) venom by polyclonal antibody raised against the eastern regional venom: A comparative study of the venoms from three different geographical distributions. Int Immunopharmacol (2006) 0.96
Indian krait bite poisoning. Ceylon Med J (1982) 0.94
Investigating pressure bandaging for snakebite in a simulated setting: bandage type, training and the effect of transport. Emerg Med Australas (2009) 0.94
Clinico-epidemiological features of snakebite: a study from Eastern Nepal. Trop Doct (2004) 0.93
Neurotoxic envenoming by the Sri Lankan krait (Bungarus ceylonicus) complicated by traditional treatment and a reaction to antivenom. Trans R Soc Trop Med Hyg (1994) 0.92
The Ebbinghaus retention curve: training does not increase the ability to apply pressure immobilisation in simulated snake bite--implications for snake bite first aid in the developing world. Trans R Soc Trop Med Hyg (2008) 0.92
Identifying the biting species in snakebite by clinical features: an epidemiological tool for community surveys. Trans R Soc Trop Med Hyg (2006) 0.91
Envenoming bites by kraits: the biological basis of treatment-resistant neuromuscular paralysis. Brain (2005) 0.91
A critical reappraisal of the use of enzyme-linked immunosorbent assays in the study of snake bite. Toxicon (1986) 0.90
Snake bite in Chittagong Division, Bangladesh: a study of bitten patients who developed no signs of systemic envenoming. Trans R Soc Trop Med Hyg (2010) 0.89
Snake antivenom product guidelines in India: "the devil is in the details". Wilderness Environ Med (2007) 0.89
Krait bite requiring high dose antivenom: a case report. Southeast Asian J Trop Med Public Health (2002) 0.88
Complex regional pain syndrome (CRPS) type-1 following snake bite: a case report. Nepal Med Coll J (2008) 0.88
Epidemiology of snakebites based on field survey in Chitwan and Nawalparasi districts, Nepal. J Med Toxicol (2007) 0.87
A study of the current knowledge base in treating snake bite amongst doctors in the high-risk countries of India and Pakistan: does snake bite treatment training reflect local requirements? Trans R Soc Trop Med Hyg (2008) 0.85
Snakes of medical significance in India: the first reported case of envenoming by the Levantine viper (Macrovipera lebetina). Wilderness Environ Med (2008) 0.84
PCR-based DNA typing of saliva stains recovered from human skin. J Forensic Sci (1997) 0.84
Envenoming by the viperid snake Eristicophis macmahonii. Toxicon (2005) 0.83
The African challenge. Lancet (2002) 0.82
Resolution of neurotoxicity with anticholinesterase therapy in death-adder envenomation. Med J Aust (1988) 0.82
Snake bite poisoning presenting as early morning neuroparalytic syndrome in jhuggi dwellers. J Assoc Physicians India (1986) 0.82
ELISA for the detection of venoms from four medically important snakes of India. Toxicon (1999) 0.81
Snake antivenom research: the importance of case definition. Emerg Med J (2005) 0.81
Use of egg yolk antibody (IgY) as an immunoanalytical tool in the detection of Indian cobra (Naja naja naja) venom in biological samples of forensic origin. Toxicon (2006) 0.81
Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection. J Immunol Methods (2003) 0.81
Routine antibiotic therapy in the management of the local inflammatory swelling in venomous snakebites: results of a placebo-controlled study. Ceylon Med J (2005) 0.81
A new avidin-biotin optical immunoassay for the detection of beta-bungarotoxin and application in diagnosis of experimental snake envenomation. J Immunol Methods (2002) 0.80
The "worldwide shortage" of antisnake venom: is the only right answer "produce more" or is it also "use it smarter?". Wilderness Environ Med (2008) 0.80
Venomous snakebite in Thailand. II: Clinical experience. Mil Med (1998) 0.80
Development of a species-specific ELISA for Brazilian pit-viper venoms. Braz J Med Biol Res (1990) 0.80
Venom phospholipases of Russell's vipers from Myanmar and eastern India--cloning, characterization and phylogeographic analysis. Biochim Biophys Acta (2007) 0.79
Snake bite in the Thar Desert. J Pak Med Assoc (1998) 0.79
Bite of a sea snake (Hydrophis spiralis): a case report from Sri Lanka. J Trop Med Hyg (1994) 0.78
Two Sri Lankan cases of identified sea snake bites, without envenoming. Toxicon (2005) 0.78
The global snakebite crisis--a public health issue misunderstood, not neglected. Wilderness Environ Med (2009) 0.78
Management of cobra bite by artificial respiration and supportive therapy. J Med Assoc Thai (1994) 0.77
Epidemiology of sea-snake bites. J Trop Med Hyg (1975) 0.77
Strong myotoxic activity of Trimeresurus malabaricus venom: role of metalloproteases. Mol Cell Biochem (2006) 0.77
Scorpion envenomation. N Engl J Med (2014) 4.38
Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol (2008) 2.48
Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg (2004) 2.42
Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis (2011) 2.30
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis (2009) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg (2004) 1.57
NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness. PLoS Negl Trop Dis (2010) 1.55
Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop Med Int Health (2009) 1.48
Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis (2010) 1.42
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect (2007) 1.40
Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis (2008) 1.39
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health (2010) 1.36
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother (2005) 1.34
The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health (2010) 1.30
Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin Emerg Drugs (2012) 1.24
Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis (2010) 1.23
Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal. Infect Genet Evol (2006) 1.17
Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol (2010) 1.16
Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One (2010) 1.12
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo. Clin Infect Dis (2012) 1.11
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg (2008) 1.09
Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis. PLoS Negl Trop Dis (2011) 1.09
Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. Confl Health (2011) 1.03
Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop (2006) 1.03
Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton) (2011) 0.99
Chronic renal failure associated with heavy metal contamination of drinking water: a clinical report from a small village in Maharashtra. Clin Toxicol (Phila) (2010) 0.98
Travel-related infection in European travelers, EuroTravNet 2011. J Travel Med (2014) 0.97
Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal. J Health Popul Nutr (2007) 0.97
The greater black krait (Bungarus niger), a newly recognized cause of neuro-myotoxic snake bite envenoming in Bangladesh. Brain (2010) 0.96
High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B. Antimicrob Agents Chemother (2010) 0.96
Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis. PLoS Negl Trop Dis (2012) 0.96
Effectiveness of rapid transport of victims and community health education on snake bite fatalities in rural Nepal. Am J Trop Med Hyg (2013) 0.95
Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open (2012) 0.94
Rapid diagnostic tests for a coordinated approach to fever syndromes in low-resource settings. Clin Infect Dis (2012) 0.93
Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan. Parasit Vectors (2012) 0.92
Treatment options for second-stage gambiense human African trypanosomiasis. Expert Rev Anti Infect Ther (2014) 0.92
Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency? PLoS Negl Trop Dis (2012) 0.91
Drug utilization pattern and effectiveness analysis in diabetes mellitus at a tertiary care centre in eastern Nepal. Indian J Physiol Pharmacol (2012) 0.91
Fatal neurotoxic envenomation from the bite of a Lesser Black Krait (Bungarus lividus) in Nepal. Southeast Asian J Trop Med Public Health (2011) 0.91
Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg (2011) 0.90
Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya. PLoS Negl Trop Dis (2013) 0.90
Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya. Am J Trop Med Hyg (2013) 0.90
Snake bite in Chittagong Division, Bangladesh: a study of bitten patients who developed no signs of systemic envenoming. Trans R Soc Trop Med Hyg (2010) 0.89
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Trop Med Int Health (2012) 0.89
The alcohol use disorders identification test (AUDIT): validation of a Nepali version for the detection of alcohol use disorders and hazardous drinking in medical settings. Subst Abuse Treat Prev Policy (2012) 0.88
Severe Neurotoxic Envenoming and Cardiac Complications after the Bite of a 'Sind Krait' (Bungarus cf. sindanus) in Maharashtra, India. Trop Med Health (2012) 0.88
African tick-bite fever: four cases among Swiss travelers returning from South Africa. J Travel Med (2004) 0.87
Malaria control in Nepal 1963-2012: challenges on the path towards elimination. Malar J (2014) 0.87
Kala-azar control, Uganda. Emerg Infect Dis (2007) 0.87
Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infect Immun (2009) 0.86
Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS Negl Trop Dis (2012) 0.86
Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country. Trop Med Int Health (2012) 0.85
[Chagas disease in Switzerland: managing an emerging infection and interrupting its transmission]. Rev Med Suisse (2008) 0.85
Spatio-temporal distribution of malaria and its association with climatic factors and vector-control interventions in two high-risk districts of Nepal. Malar J (2014) 0.84
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. J Infect Dis (2012) 0.84
Pediatric Chagas disease in Europe: 45 cases from Spain and Switzerland. Pediatr Infect Dis J (2014) 0.83
Criminal poisoning of commuters in Bangladesh: prospective and retrospective study. Forensic Sci Int (2008) 0.83
Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment. BMC Infect Dis (2014) 0.83
Novel conopeptides of the I-superfamily occur in several clades of cone snails. Toxicon (2004) 0.82
Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? Trop Med Int Health (2014) 0.82
Prevalences of tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in Ixodes ricinus populations of the Rhine-Main region, Germany. Ticks Tick Borne Dis (2013) 0.82
Isolation, toxicity and amino terminal sequences of three major neurotoxins in the venom of Malayan krait (Bungarus candidus) from Thailand. J Biochem (2003) 0.81
Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey. PLoS Negl Trop Dis (2012) 0.80
A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming. Bull World Health Organ (2014) 0.80
Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India. Trop Med Int Health (2012) 0.79
Diphyllobothrium latum outbreak from marinated raw perch, Lake Geneva, Switzerland. Emerg Infect Dis (2007) 0.79
Kala azar associated with malaria. Arch Pathol Lab Med (2002) 0.79
Functional hypervariability and gene diversity of cardioactive neuropeptides. J Biol Chem (2010) 0.78
Appropriate larval food quality and quantity for Aedes albopictus (Diptera: Culicidae). J Med Entomol (2013) 0.78
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure? Malar J (2006) 0.78
Cardiovascular autonomic function and vibration perception threshold in type 2 diabetes mellitus. J Diabetes Complications (2012) 0.77
Vaccine-preventable diseases in long-term expatriates. J Travel Med (2005) 0.77
High immunogenicity of delayed third dose of hepatitis B vaccine in travellers. Vaccine (2007) 0.76
Complete amino acid sequence and phylogenetic analysis of a long-chain neurotoxin from the venom of the African banded water cobra, Boulengerina annulata. Toxicon (2004) 0.76
Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan. J Travel Med (2013) 0.75
Comparison of complications in diabetic outpatients with or without mental illness. Indian J Endocrinol Metab (2013) 0.75
Clinical profile of patients hospitalized with heart failure in Bharatpur, Nepal. J Cardiovasc Thorac Res (2012) 0.75
Outcome of sepsis-associated acute kidney injury in an intensive care unit: an experience from a tertiary care center of central Nepal. Saudi J Kidney Dis Transpl (2014) 0.75
Percutaneous coronary intervention without onsite cardiac surgery backup. JNMA J Nepal Med Assoc (2013) 0.75
[Old World cutaneous leishmaniasis]. Rev Med Suisse (2013) 0.75
Screening and Management of Children at Risk for Chagas Disease in Nonendemic Areas. Pediatr Infect Dis J (2016) 0.75
Correction: High blood levels of lead in children aged 6-36 months in Kathmandu Valley, Nepal: A cross-sectional study of associated factors. PLoS One (2017) 0.75
Towards universal health coverage in India. Lancet (2011) 0.75
[Not Available]. Rev Med Suisse (2016) 0.75
Biochemical and biological activities of the venom of a new species of pitviper from Vietnam, Triceratolepidophis sieversorum. Toxicon (2003) 0.75
[Malaria and children who travel - prophylaxis and therapy]. Ther Umsch (2013) 0.75
Clinical features and histological patterns of lupus nephritis in Eastern Nepal. Saudi J Kidney Dis Transpl (2011) 0.75
[Plasmodium vivax, a parasite coming out of the shadows]. Rev Med Suisse (2016) 0.75
Checking for plagiarism, duplicate publication, and text recycling. Lancet (2011) 0.75